These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7504150)

  • 1. Detection of P glycoprotein activity on normal and leukemic CD34+ cells.
    Drenou B; Fardel O; Amiot L; Fauchet R
    Leuk Res; 1993 Dec; 17(12):1031-5. PubMed ID: 7504150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies.
    Beck J; Gekeler V; Ringger M; Handgretinger R; Niethammer D
    Cancer Lett; 1996 Feb; 99(2):197-207. PubMed ID: 8616825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.
    Drach D; Zhao S; Drach J; Mahadevia R; Gattringer C; Huber H; Andreeff M
    Blood; 1992 Dec; 80(11):2729-34. PubMed ID: 1360266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of activity of P-glycoprotein (P-170) in de novo acute lymphoblastic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Thaler J; Gotwald M; Hofmann J
    Blood; 1993 Dec; 82(11):3505-7. PubMed ID: 7902138
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
    J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.
    Goasguen JE; Dossot JM; Fardel O; Le Mee F; Le Gall E; Leblay R; LePrise PY; Chaperon J; Fauchet R
    Blood; 1993 May; 81(9):2394-8. PubMed ID: 8097634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells.
    te Boekhorst PA; de Leeuw K; Schoester M; Wittebol S; Nooter K; Hagemeijer A; Löwenberg B; Sonneveld P
    Blood; 1993 Nov; 82(10):3157-62. PubMed ID: 7693039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
    Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
    Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.
    Broxterman HJ; Sonneveld P; Feller N; Ossenkoppele GJ; Währer DC; Eekman CA; Schoester M; Lankelma J; Pinedo HM; Löwenberg B; Schuurhuis GJ
    Blood; 1996 Jun; 87(11):4809-16. PubMed ID: 8639853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA; Gore SD; Stone KD; Civin CI
    Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
    Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
    Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells.
    Wagner-Souza K; Diamond HR; Ornellas MH; Gomes BE; Almeida-Oliveira A; Abdelhay E; Bouzas LF; Rumjanek VM
    Int J Mol Med; 2008 Aug; 22(2):237-42. PubMed ID: 18636179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early steps of the P-glycoprotein expression in cell cultures studied with vital fluorochrome.
    Egudina SV; Stromskaya TP; Frolova EA; Stavrovskaya AA
    FEBS Lett; 1993 Aug; 329(1-2):63-6. PubMed ID: 8102609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.
    Hanson CA; Ross CW; Schnitzer B
    Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
    Baersch G; Baumann M; Meltzer J; Möllers T; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
    Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
    Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
    Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
    Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of P-glycoprotein in normal and leukemic cells.
    Tiirikainen MI; Syrjälä MT; Jansson SE; Krusius T
    Ann Hematol; 1992 Sep; 65(3):124-30. PubMed ID: 1356449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses.
    Paietta E; Andersen J; Racevskis J; Gallagher R; Bennett J; Yunis J; Cassileth P; Wiernik PH
    Leukemia; 1994 Jun; 8(6):968-73. PubMed ID: 7516029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.
    Eytan GD; Regev R; Oren G; Hurwitz CD; Assaraf YG
    Eur J Biochem; 1997 Aug; 248(1):104-12. PubMed ID: 9310367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.